Literature DB >> 25584524

Measuring substantial reductions in activity.

Charles Schafer1, Meredyth Evans, Leonard A Jason, Suzanna So, Abigail Brown.   

Abstract

The case definitions for Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS), ME, and CFS each include a disability criterion requiring substantial reductions in activity in order to meet diagnostic criteria. Difficulties have been encountered in defining and operationalizing the substantial reduction disability criterion within these various illness definitions. The present study sought to relate measures of past and current activities in several domains including the SF-36, an objective measure of activity (e.g., actigraphy), a self-reported quality of life scale, and measures of symptom severity. Results of the study revealed that current work activities had the highest number of significant associations with domains such as the SF-36 subscales, actigraphy, and symptom scores. As an example, higher self-reported levels of current work activity were associated with better health. This suggests that current work related activities may provide a useful domain for helping operationalize the construct of substantial reductions in activity.

Entities:  

Keywords:  Myalgic Encephalomyelitis; Myalgic Encephalomyelitis/chronic fatigue syndrome; activity; chronic fatigue syndrome; substantial reductions

Mesh:

Year:  2015        PMID: 25584524      PMCID: PMC4295629          DOI: 10.1080/10852352.2014.973242

Source DB:  PubMed          Journal:  J Prev Interv Community        ISSN: 1085-2352


  18 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Development of a fatigue scale.

Authors:  T Chalder; G Berelowitz; T Pawlikowska; L Watts; S Wessely; D Wright; E P Wallace
Journal:  J Psychosom Res       Date:  1993       Impact factor: 3.006

3.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

4.  Measuring substantial reductions in functioning in patients with chronic fatigue syndrome.

Authors:  Leonard Jason; Molly Brown; Meredyth Evans; Valerie Anderson; Athena Lerch; Abigail Brown; Jessica Hunnell; Nicole Porter
Journal:  Disabil Rehabil       Date:  2010-07-09       Impact factor: 3.033

5.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

6.  Depression in fatiguing illness: comparing patients with chronic fatigue syndrome, multiple sclerosis and depression.

Authors:  S K Johnson; J DeLuca; B H Natelson
Journal:  J Affect Disord       Date:  1996-06-20       Impact factor: 4.839

7.  Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial.

Authors:  M Sharpe; K Hawton; S Simkin; C Surawy; A Hackmann; I Klimes; T Peto; D Warrell; V Seagroatt
Journal:  BMJ       Date:  1996-01-06

8.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

Review 9.  Myalgic encephalomyelitis: International Consensus Criteria.

Authors:  B M Carruthers; M I van de Sande; K L De Meirleir; N G Klimas; G Broderick; T Mitchell; D Staines; A C P Powles; N Speight; R Vallings; L Bateman; B Baumgarten-Austrheim; D S Bell; N Carlo-Stella; J Chia; A Darragh; D Jo; D Lewis; A R Light; S Marshall-Gradisnik; I Mena; J A Mikovits; K Miwa; M Murovska; M L Pall; S Stevens
Journal:  J Intern Med       Date:  2011-08-22       Impact factor: 8.989

Review 10.  The Quality of Life Scale (QOLS): reliability, validity, and utilization.

Authors:  Carol S Burckhardt; Kathryn L Anderson
Journal:  Health Qual Life Outcomes       Date:  2003-10-23       Impact factor: 3.186

View more
  4 in total

1.  Assessing current functioning as a measure of significant reduction in activity level.

Authors:  Taylor Thorpe; Stephanie McManimen; Kristen Gleason; Jamie Stoothoff; Julia L Newton; Elin Bolle Strand; Leonard A Jason
Journal:  Fatigue       Date:  2016-07-19

2.  Operationalizing Substantial Reduction in Functioning Among Young Adults with Chronic Fatigue Syndrome.

Authors:  Kristen D Gleason; Jamie Stoothoff; Damani McClellan; Stephanie McManimen; Taylor Thorpe; Ben Z Katz; Leonard A Jason
Journal:  Int J Behav Med       Date:  2018-08

3.  The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions.

Authors:  Leonard A Jason; Madison Sunnquist
Journal:  Front Pediatr       Date:  2018-11-06       Impact factor: 3.418

4.  Myalgic encephalomyelitis and chronic fatigue syndrome case definitions: effects of requiring a substantial reduction in functioning.

Authors:  Samantha Scartozzi; Madison Sunnquist; Leonard A Jason
Journal:  Fatigue       Date:  2019-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.